WZ4003 299 may warrant clinical trials to

may warrant clinical trials to assess its potential in the treatment of different painful or inflammatory conditions

PubMed PMID: 17785584

InChiKey: HSTZMXCBWJGKHG-CUYWLFDKSA-N

InChiKey: PBSOJKPTQWWJJD-ZBDZJSKLSA-N

WZ4003 299 may warrant clinical trials toWZ4003 is a selective inhibitors of the LKB1 tumour suppressor activated NUAK kinases. WZ4003 inhibits both NUAK isoforms (IC50 for NUAK1 is 20 nM and for NUAK2 is 100 nM). WZ4003 displays extreme selectivity and do not significantly inhibit the activity of 139 other kinases that were tested including ten AMPK family members. In all cell lines tested, WZ4003 inhibits the phosphorylation of the only well characterized substrate, MYPT1 (myosin phosphate